![John Tucker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Tucker
Directeur Général chez
Xylocor Therapeutics, Inc.
Profil
John H.
Tucker is President, Chief Executive Officer & Director at Xylocor Therapeutics, Inc. since 2026.
Mr. Tucker is Director at Eleusis Holdings Ltd. since 2021.
Formerly, Mr. Tucker was President, Chief Executive Officer & Director at scPharmaceuticals, Inc. from 2017 to 2025.
Mr. Tucker was President, Chief Executive Officer & Treasurer at ASC Liquidation Corp.
from 2016 to 2017.
Mr. Tucker was Chief Executive Officer & Director at Alcresta Therapeutics, Inc. from 2014 to 2016.
Mr. Tucker was Chief Executive Officer-North American Business at Nelson Bach Usa Ltd. from 2013 to 2014.
Mr. Tucker was Director at Eleusis Holdings Ltd. from 2021 to 2022.
Mr. Tucker was Chief Commercial Officer & Senior Vice President at Incline Therapeutics, Inc. from 2012 to 2013.
Mr. Tucker was Senior Vice President-Commercial Operations at AMAG Pharmaceuticals, Inc. in 2012.
Mr. Tucker was President-US Operations at Basilea Pharmaceuticals Ltd. from 2007 to 2011.
Mr. Tucker was Executive Vice President-Sales & Marketing at Indevus Pharmaceuticals, Inc. from 2002 to 2007.
Education includes undergraduate studies at Plymouth State University and an MBA from Southern New Hampshire University.
Postes actifs de John Tucker
| Sociétés | Poste | Début |
|---|---|---|
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Directeur Général | 05/03/2026 |
Anciens postes connus de John Tucker
| Sociétés | Poste | Fin |
|---|---|---|
| SCPHARMACEUTICALS INC. | Directeur Général | 07/10/2025 |
Eleusis Holdings Ltd.
 Eleusis Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development of psychedelic infusion therapies | Directeur/Membre du Conseil | 01/10/2022 |
ASC Liquidation Corp.
 ASC Liquidation Corp. Environmental ServicesIndustrial Services Provides wastewater management services | Directeur Général | 01/01/2017 |
Alcresta Therapeutics, Inc.
 Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops enzyme-based products that deliver enzymatic solutions to those living with rare diseases | Directeur Général | 01/07/2016 |
Nelson Bach Usa Ltd.
 Nelson Bach Usa Ltd. Pharmaceuticals: OtherHealth Technology Manufactures flower essence | Corporate Officer/Principal | 01/04/2014 |
Formation de John Tucker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
30
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Indevus Pharmaceuticals, Inc.
 Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical compounds for urology, gynecology, and infectious diseases | Health Technology |
ASC Liquidation Corp.
ASC Liquidation Corp. Environmental ServicesIndustrial Services Provides wastewater management services | Industrial Services |
Incline Therapeutics, Inc.
 Incline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Plymouth State University
 Plymouth State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Southern New Hampshire University
 Southern New Hampshire University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops enzyme-based products that deliver enzymatic solutions to those living with rare diseases | Health Technology |
scPharmaceuticals, Inc.
 scPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products to the cardiovascular and infectious diseases | Health Technology |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Health Technology |
Basilea Pharmaceuticals Ltd.
 Basilea Pharmaceuticals Ltd. Medical DistributorsDistribution Services Distributes pharmaceutical products | Distribution Services |
Nelson Bach Usa Ltd.
Nelson Bach Usa Ltd. Pharmaceuticals: OtherHealth Technology Manufactures flower essence | Health Technology |
Eleusis Holdings Ltd.
Eleusis Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development of psychedelic infusion therapies | Commercial Services |
